Works matching AU Segami, Kenki

Results: 19
    1

    A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 6, p. 1162, doi. 10.1007/s10147-025-02748-8
    By:
    • Aoyama, Toru;
    • Ooki, Akira;
    • Oba, Koji;
    • Nishikawa, Kazuhiro;
    • Kawabata, Ryohei;
    • Honda, Michitaka;
    • Maeda, Hiromichi;
    • Kanda, Mitsuro;
    • Sugiyama, Keiji;
    • Makiyama, Akitaka;
    • Segami, Kenki;
    • Takahashi, Masazumi;
    • Shindo, Yoshiaki;
    • Namikawa, Tsutomu;
    • Oshima, Takashi;
    • Katayama, Aya;
    • Shiosakai, Kazuhito;
    • Sakamoto, Junichi
    Publication type:
    Article
    2
    3
    4

    Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative Treatment.

    Published in:
    In Vivo, 2024, v. 38, n. 2, p. 904, doi. 10.21873/invivo.13517
    By:
    • MOMOKO FUKUDA;
    • TORU AOYAMA;
    • ITARU HASHIMOTO;
    • YUKIO MAEZAWA;
    • AYA KATO;
    • KENTARO HARA;
    • KEISUKE KAZAMA;
    • KEISUKE KOMORI;
    • AYAKO TAMAGAWA;
    • HARUHIKO CHO;
    • TETSUSHI ISHIGURO;
    • KENKI SEGAMI;
    • MASATO NAKAZONO;
    • KAZUKI OTANI;
    • SHO SAWAZAKI;
    • MASAKATSU NUMATA;
    • SHINNOSUKE KAWAHARA;
    • TAKASHI OSHIMA;
    • AYA SAITO;
    • NORIO YUKAWA
    Publication type:
    Article
    5
    6

    The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.

    Published in:
    In Vivo, 2024, v. 38, n. 2, p. 890, doi. 10.21873/invivo.13515
    By:
    • TORU AOYAMA;
    • AYA KATO;
    • ITARU HASHIMOTO;
    • YUKIO MAEZAWA;
    • KENTARO HARA;
    • KEISUKE KAZAMA;
    • KEISUKE KOMORI;
    • HIROSHI TAMAGAWA;
    • AYAKO TAMAGAWA;
    • SHINSUKE NAGASAWA;
    • HARUHIKO CHO;
    • KENKI SEGAMI;
    • MASATO NAKAZONO;
    • KAZUKI OTANI;
    • SHO SAWAZAKI;
    • MASAKATSU NUMATA;
    • NATSUMI KAMIYA;
    • SUZUE YOSHIZAWA;
    • SHINNOSUKE KAWAHARA;
    • TAKASHI OSHIMA
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer.

    Published in:
    In Vivo, 2021, v. 35, n. 5, p. 2771, doi. 10.21873/invivo.12562
    By:
    • KENKI SEGAMI;
    • TORU AOYAMA;
    • YUKIHIKO HIROSHIMA;
    • KEISUKE KOMORI;
    • ITARU HASHIMOTO;
    • HAYATO WATANABE;
    • KAZUKI KANO;
    • SHINSUKE NAGASAWA;
    • MASATO NAKAZONO;
    • YUKIO MAEZAWA;
    • HIROHITO FUJIKAWA;
    • MASAKATSU NUMATA;
    • TAKANOBU YAMADA;
    • HIROSHI TAMAGAWA;
    • NAOTO YAMAMOTO;
    • TAKASHI OGATA;
    • MANABU SIOZAWA;
    • NORIO YUKAWA;
    • SOICHIRO MORINAGA;
    • YASUSHI RINO
    Publication type:
    Article
    15
    16
    17
    18
    19

    Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 6, p. 1963, doi. 10.1245/s10434-015-5080-4
    By:
    • Aoyama, Toru;
    • Sato, Tsutomu;
    • Segami, Kenki;
    • Maezawa, Yukio;
    • Kano, Kazuki;
    • Kawabe, Taiichi;
    • Fujikawa, Hirohito;
    • Hayashi, Tsutomu;
    • Yamada, Takanobu;
    • Tsuchida, Kazuhito;
    • Yukawa, Norio;
    • Oshima, Takashi;
    • Rino, Yasushi;
    • Masuda, Munetaka;
    • Ogata, Takashi;
    • Cho, Haruhiko;
    • Yoshikawa, Takaki
    Publication type:
    Article